M. Tomirotti

1.7k citations

32 papers · 904 indexed · 1 hit paper · h-index 14

Impact in

Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in ⓘ

Oncology 17
- HER2/EGFR in Cancer Research 3
- Vascular Tumors and Angiosarcomas 3
Pulmonary and Respiratory Medicine 15
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 4
- Gastric Cancer Management and Outcomes 3
- Sarcoma Diagnosis and Treatment 3

Co-authors: A. Scanni (16 shared papers)Gabriella Farina (6 shared papers)Marina Chiara Garassino (4 shared papers)Olga Martelli (4 shared papers)Roberto Labianca (4 shared papers)Silvia Marsoni (3 shared papers)Flavia Longo (3 shared papers)Mirko Marabese (3 shared papers)
Journals: Journal of Clinical Oncology (3 papers)Oncology (2 papers)Tumori Journal (11 papers)Blood Coagulation & Fibrinolysis (1 paper)BMJ Open (1 paper)
Partner nations: Italy Switzerland Ireland

In The Last Decade

M. Tomirotti

32 papers receiving 871 citations

Hit Papers

align trajectories log scale

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial 2013 · 376 citations

Peers

Countries citing papers authored by M. Tomirotti

Since Specialization

Citations

This map shows the geographic impact of M. Tomirotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Tomirotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Tomirotti more than expected).

Fields of papers citing papers by M. Tomirotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Tomirotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Tomirotti. The network helps show where M. Tomirotti may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Tomirotti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Tomirotti Line = papers co-authored together M. Tomirotti links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial The Lancet Oncology ·Marina Chiara Garassino, Olga Martelli, Massimo Broggini, Gabriella Farina, Silvio Veronese, Eliana Rulli, F Bianchi, Anna Bettini, Flavia Longo, Luca Moscetti, M. Tomirotti, Mirko Marabese, Monica Ganzinelli, Calogero Lauricella, Roberto Labianca, Irene Floriani, Giuseppe Giaccone, Valter Torri, A. Scanni, Silvia Marsoni Hit paper breakdown →	2013	376
2	Complications of Subcutaneous Infusion Port in the General Oncology Population Oncology ·C Ballarini, Mattia Intra, Andrea Pisani Ceretti, Andrea Cordovana, Mauro Pagani, Gabriella Farina, Serafina Perrone, M. Tomirotti, A. Scanni, G.P. Spina	1999	99
3	Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients Oncology ·Andrés J.M. Ferreri, Michele Reni, Stefania Dell’Oro, Fabio Ciceri, Massimo Bernardi, Lionello Camba, Maurilio Ponzoni, Maria Rosa Terreni, M. Tomirotti, Michele Spina, Eugenio Villa	2001	76
4	Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology European Journal of Cancer ·Matteo Lambertini, Michela Cinquini, Ivan Moschetti, Fedro A. Peccatori, Paola Anserini, Mario Valenzano Menada, M. Tomirotti, Lucia Del Mastro	2016	65
5	TAILOR: Phase III trial comparing erlotinib with docetaxel in the second-line treatment of NSCLC patients with wild-type (wt) EGFR. Journal of Clinical Oncology ·Marina Chiara Garassino, Olga Martelli, Anna Bettini, Irene Floriani, Elena Copreni, Calogero Lauricella, Monica Ganzinelli, Mirko Marabese, Massimo Broggini, Silvio Veronese, Giorgio Gherardi, Flavia Longo, Agnese Fabbri, M. Tomirotti, Oscar Alabiso, Maria Giuseppa Sarobba, Roberto Labianca, Silvia Marsoni, Gabriella Farina, A. Scanni	2012	43
6	Serum Copper and Ceruloplasmin Levels in Patients with Neoplasias Localized in the Stomach, Large Intestine or Lung Tumori Journal ·A. Scanni, Luciano Licciardello, Marinella Trovato, M. Tomirotti, M Biraghi	1977	37
7	Ischemic Cardiopathy from CIS-Diamminedichloroplatinum (CDDP) Tumori Journal ·M. Tomirotti, Romeo Riundi, Sergio Pillici, Antonio Ungaro, D Pedretti, Silvia Villa, A. Scanni	1984	31
8	TAILOR: A phase III trial comparing erlotinib with docetaxel as the second-line treatment of NSCLC patients with wild-type (wt) EGFR. Journal of Clinical Oncology ·Marina Chiara Garassino, Olga Martelli, Anna Bettini, Irene Floriani, Elena Copreni, Calogero Lauricella, Monica Ganzinelli, Mirko Marabese, Massimo Broggini, Silvio Veronese, Giorgio Gherardi, Flavia Longo, Agnese Fabbri, M. Tomirotti, Oscar Alabiso, Maria Giuseppa Sarobba, Roberto Labianca, Silvia Marsoni, Gabriella Farina, A. Scanni	2012	22
9	Paclitaxel-Dependent Prolonged and Persistent Complete Remission Four Years from First Recurrence of Secondary Breast Angiosarcoma Tumori Journal ·Donatella Gambini, Roberto Visintin, Elisa Locatelli, Barbara Galassi, Claudia Bareggi, Letterio Runza, Francesco Onida, M. Tomirotti	2009	19
10	Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma. PubMed ·Donatella Gambini, Roberto Visintin, Elisa Locatelli, Barbara Galassi, Claudia Bareggi, Letterio Runza, Francesco Onida, M. Tomirotti	2010	17
11	Variations in Serum Copper and Ceruloplasmin Levels in Advanced Gastrointestinal Cancer Treated with Polychemotherapy Tumori Journal ·A. Scanni, M. Tomirotti, Luciano Licciardello, Ennio Annibali, M Biraghi, Marinella Trovato, Mario Fittipaldi, Paola Adamoli, G Curtarelli	1979	15
12	RECOVERY OF RESPONSE TO ADRIAMYCIN AND CYCLOPHOSPHAMIDE BY LONIDAMINE IN PREVIOUSLY TREATED METASTATIC BREAST-CANCER PATIENTS International Journal of Oncology ·M. Tomirotti, Grisi Bernardo, C. Epifani, Roberto Biasioli, Roberto Franchi, F Mensi, P Carnaghi, G. Schieppati, A. Scanni	1993	15
13	Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Receptor Mutations Clinical Lung Cancer ·Gabriella Farina, Flavia Longo, Olga Martelli, Ida Pavese, Andrea Mancuso, Luca Moscetti, Roberto Labianca, Alessandro Bertolini, Enrico Cortesi, A. Farris, Daniele Fagnani, M.C. Locatelli, Giuseppe Valmadre, Antonio Ardizzoia, M. Tomirotti, Eliana Rulli, Marina Chiara Garassino, A. Scanni	2011	13
14	Cisplatin (P) versus Cyclophosphamide, Adriamycin and Cisplatin (CAP) for Stage III-IV Epithelial Ovarian Carcinoma: A Prospective Randomized Trial Tumori Journal ·M. Tomirotti, Silvia Perrone, Paolo Giè, R Canaletti, A Carpi, Roberto Biasoli, Franco Lombardi, Anita Giovanninetti, F Mensi, Silvia Villa, A. Scanni	1988	13
15	Pharmacokinetics and bioavailability of metoclopramide nasal spray versus metoclopramide intravenous in healthy volunteers and cancer patients. PubMed ·F. Scaglione, A. Scanni, M. Tomirotti, M. Dimaiuta, Pier Alda Ferrari, F. Fraschini	1993	10
16	Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy The Breast ·Giuseppe Gullo, Daniela Bettio, Monica Zuradelli, Giovanna Masci, Laura Giordano, Claudia Bareggi, M. Tomirotti, Piermario Salvini, Letterio Runza, Nicla La Verde, Armando Santoro	2013	8
17	Efficacy and tolerability of nasally administered compared to parenterally administered metoclopramide in the symptomatic treatment of chemotherapy-induced emesis in cancer outpatients A controlled clinical study Supportive Care in Cancer ·M. Tomirotti, M. Dimaiuta, Maurizio Confalonieri, A. Scanni	1994	6
18	Secondary Breast Angiosarcoma and Paclitaxel-dependent Prolonged Disease Control: Report of Two Cases and Review of the Literature Tumori Journal ·Donatella Gambini, Roberto Visintin, Elisa Locatelli, Claudia Bareggi, Barbara Galassi, Letterio Runza, Concerta Blundo, Irina Sosnovskikh, M. Tomirotti	2015	6
19	Cancer and Pregnancy Annals of Oncology ·M. Tomirotti	2002	5
20	Conflict of interest among Italian medical oncologists: a national survey BMJ Open ·Andrea DeCensi, Gianmauro Numico, Enzo Ballatori, Fabrizio Artioli, Mario Clerico, Luisa Fioretto, Virginia Livellara, Benedetta Ruggeri, M. Tomirotti, Claudio Verusio, Fausto Roila	2018	5

About M. Tomirotti

M. Tomirotti is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Emergency Medical Services and Internal Medicine, having authored 32 papers that have together received 904 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Diagnosis and Treatment (4 papers), HER2/EGFR in Cancer Research (3 papers), Gastric Cancer Management and Outcomes (3 papers), Breast Cancer Treatment Studies (3 papers), Vascular Tumors and Angiosarcomas (3 papers), Sarcoma Diagnosis and Treatment (3 papers) and Breast Lesions and Carcinomas (3 papers). The work is most often cited by research in Oncology (498 citations), Pulmonary and Respiratory Medicine (539 citations), Emergency Medical Services (93 citations), Reproductive Medicine (60 citations) and Genetics (66 citations). M. Tomirotti has collaborated with scholars based in Italy, Switzerland and Ireland. Frequent co-authors include A. Scanni, Gabriella Farina, Marina Chiara Garassino, Olga Martelli, Roberto Labianca, Silvia Marsoni, Flavia Longo, Mirko Marabese, Monica Ganzinelli and Calogero Lauricella. Their work appears in journals such as Journal of Clinical Oncology, Oncology, Tumori Journal, Blood Coagulation & Fibrinolysis and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact